Log in

Merit Medical Systems Stock Price, Forecast & Analysis (NASDAQ:MMSI)

-1.02 (-3.82 %)
(As of 11/12/2019 04:28 AM ET)
Today's Range
Now: $25.66
50-Day Range
MA: $28.70
52-Week Range
Now: $25.66
Volume42,245 shs
Average Volume603,624 shs
Market Capitalization$1.42 billion
P/E Ratio15.18
Dividend YieldN/A
Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
Current SymbolNASDAQ:MMSI



Sales & Book Value

Annual Sales$882.75 million
Cash Flow$2.91 per share
Book Value$17.20 per share


Net Income$42.02 million


Market Cap$1.42 billion
Next Earnings Date2/25/2020 (Estimated)

Receive MMSI News and Ratings via Email

Sign-up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.

Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) released its earnings results on Wednesday, October, 30th. The medical instruments supplier reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.45 by $0.17. The medical instruments supplier earned $243.05 million during the quarter, compared to the consensus estimate of $248.53 million. Merit Medical Systems had a net margin of 1.94% and a return on equity of 9.23%. Merit Medical Systems's quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.47 earnings per share. View Merit Medical Systems' Earnings History.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Merit Medical Systems.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems issued an update on its FY19 earnings guidance on Wednesday, October, 30th. The company provided EPS guidance of $1.40-1.46 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.75. The company issued revenue guidance of $986-995 million, compared to the consensus revenue estimate of $1.01 billion.

What price target have analysts set for MMSI?

9 Wall Street analysts have issued twelve-month target prices for Merit Medical Systems' stock. Their forecasts range from $30.00 to $73.00. On average, they expect Merit Medical Systems' stock price to reach $42.75 in the next year. This suggests a possible upside of 66.6% from the stock's current price. View Analyst Price Targets for Merit Medical Systems.

What is the consensus analysts' recommendation for Merit Medical Systems?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Merit Medical Systems.

What are Wall Street analysts saying about Merit Medical Systems stock?

Here are some recent quotes from research analysts about Merit Medical Systems stock:
  • 1. Barrington Research analysts commented, "We would gently suggest that with shares down over 55% over the past few months that perhaps the miss, the guidedown, the “drama”, and even a riskier near‐term growth profile might mostly be “in the stock” at this point. We simply think the risk/reward now favors investment – even if Q3 comes in soft. We will try to make our argument in brief below." (9/12/2019)
  • 2. According to Zacks Investment Research, "Shares of Merit Medical outperformed the industry in a year’s time. Significant expansion in adjusted gross margins in recent times buoy optimism in the stock. Robust Cardiovascular unit also encourages. Management is optimistic about Merit Medical’s Becton Dickinson deal that is set for completion at the end of 2019. Cianna Medical and Vascular Insights buyouts continue to contribute to results. Management is optimistic about several new products that are slated for introduction in the second quarter of 2019. However, escalating operating expenses remains a concern for the company. Headwinds like stiff competition and higher consolidation in the healthcare industry add to the woes. Sluggishness in the Custom kits and procedure trays and Embolization devices units is also concern. The stock is overvalued at the moment." (7/1/2019)
  • 3. Needham & Company LLC analysts commented, "MMSI’s 1Q19 revenue and EPS beat consensus (due to a lower than expected tax rate). Management reiterated its 2019 revenue and EPS guidance. Organic revenue growth slowed from 4Q18 despite an easier comp. Gross margin expansion was partially offset by higher SG&A but MMSI still delivered 60 bps of Y/Y operating margin improvement. We still believe there are multiple sources of upside to revenue (e.g. BD products are organic, Cianna SCOUT would be incremental) and EPS guidance (e.g. continued margin improvement) and we reiterate our Buy rating." (4/25/2019)

Has Merit Medical Systems been receiving favorable news coverage?

Media stories about MMSI stock have trended very negative this week, according to InfoTrie. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Merit Medical Systems earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave news articles about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Merit Medical Systems.

Are investors shorting Merit Medical Systems?

Merit Medical Systems saw a increase in short interest in September. As of September 30th, there was short interest totalling 3,800,000 shares, an increase of 9.5% from the August 30th total of 3,470,000 shares. Based on an average trading volume of 901,400 shares, the short-interest ratio is currently 4.2 days. Currently, 7.1% of the shares of the company are short sold. View Merit Medical Systems' Current Options Chain.

Who are some of Merit Medical Systems' key competitors?

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), Exfo (EXFO), RTI Surgical (RTIX), Neurometrix (NURO), Under Armour (UA), Johnson & Johnson (JNJ) and NVIDIA (NVDA).

Who are Merit Medical Systems' key executives?

Merit Medical Systems' management team includes the folowing people:
  • Mr. Fred P. Lampropoulos, Chairman, CEO & Pres (Age 69)
  • Mr. Ronald A. Frost, Chief Operating Officer (Age 57)
  • Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 58)
  • Mr. Joseph C. Wright, Pres of International Division (Age 49)
  • Mr. Raul Parra Jr., CPA, CFO & Treasurer

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.71%), Massachusetts Financial Services Co. MA (1.28%), Emerald Advisers LLC (0.74%), Emerald Mutual Fund Advisers Trust (0.70%), AMI Asset Management Corp (0.70%) and Fisher Asset Management LLC (0.65%). Company insiders that own Merit Medical Systems stock include Enterprise Associates 14 New, F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Raul Jr Parra and Ronald Frost. View Institutional Ownership Trends for Merit Medical Systems.

Which major investors are selling Merit Medical Systems stock?

MMSI stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Peregrine Capital Management LLC, Russell Investments Group Ltd., Congress Asset Management Co. MA, SG Americas Securities LLC, First Trust Advisors LP, Envestnet Asset Management Inc. and New York State Teachers Retirement System. Company insiders that have sold Merit Medical Systems company stock in the last year include F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Raul Jr Parra and Ronald Frost. View Insider Buying and Selling for Merit Medical Systems.

Which major investors are buying Merit Medical Systems stock?

MMSI stock was bought by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Massachusetts Financial Services Co. MA, Emerald Advisers LLC, Emerald Mutual Fund Advisers Trust, AMI Asset Management Corp, State of New Jersey Common Pension Fund D, Comerica Bank and State of Alaska Department of Revenue. Company insiders that have bought Merit Medical Systems stock in the last two years include Enterprise Associates 14 New, Raul Jr Parra and Ronald Frost. View Insider Buying and Selling for Merit Medical Systems.

How do I buy shares of Merit Medical Systems?

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $25.66.

How big of a company is Merit Medical Systems?

Merit Medical Systems has a market capitalization of $1.42 billion and generates $882.75 million in revenue each year. The medical instruments supplier earns $42.02 million in net income (profit) each year or $1.69 on an earnings per share basis. Merit Medical Systems employs 5,783 workers across the globe.View Additional Information About Merit Medical Systems.

What is Merit Medical Systems' official website?

The official website for Merit Medical Systems is http://www.merit.com/.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]

MarketBeat Community Rating for Merit Medical Systems (NASDAQ MMSI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  297 (Vote Outperform)
Underperform Votes:  274 (Vote Underperform)
Total Votes:  571
MarketBeat's community ratings are surveys of what our community members think about Merit Medical Systems and other stocks. Vote "Outperform" if you believe MMSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/12/2019 by MarketBeat.com Staff

Featured Article: Ex-Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel